Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding Naltrexone for the Treatment of Autism

Author(s):  Wynn Tom, Brunetti Sarah

Issue:  Jul/Aug 2009 - Homone Replacement Therapy
View All Articles in Issue

Page(s):  296-299

Compounding Naltrexone for the Treatment of Autism Page 1
Compounding Naltrexone for the Treatment of Autism Page 2
Compounding Naltrexone for the Treatment of Autism Page 3
Compounding Naltrexone for the Treatment of Autism Page 4

Download in electronic PDF format for $65

Abstract:  Autism is a complex disorder that affects children. Children who present with symptoms of autism require a comprehensive evaluation by a multidisciplinary team including a psychologist, neurologist, psychiatrist, speech therapist, and other professionals who diagnose children with autism spectrum disorders. Following the diagnosis, a treatment plan is developed, which in most cases involve educational and behavioral interventions and medications. The multidisciplinary team then expands to a team of professionals to treat the disorder, the team of which includes a pharmacist. Anxiety, depression, obsessive-compulsive disorder, behavioral problems, seizures, impulsivity, and hyperactivity are the main symptoms of autism that have in many cases been successfully minimized and in some cases alleviated by proper medication.

Related Keywords: Tom Wynn, RPh, Sarah Brunetti, autism spectrum disorder, children, neurotransmitters, opioid excess, beta endorphins, brain development, naltrexone hydrochloride, opioid antagonist, narcotic inhibitor, case reports, formulation


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George
, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jul/Aug 2018
Pg. 270-278

Opioids: A Review of the Pharmacology
Ford Peter R
Jan/Feb 2000
Pg. 17-20

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 233

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 235

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A
, Fokken Dawn
Sep/Oct 2009
Pg. 386-389

Sleepless in America: Compounding with Melatonin
Wynn Tom
, Rawlings Kate
Jan/Feb 2010
Pg. 10-13

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions